Mark A. Hillman - Hillman Value Fund Portfolio Position Sizes (Q1 2026)

As of Mar 31, 2026, the Hillman Value Fund portfolio balances reported a total equity value of $144.00M across 56 publicly traded holdings. These balances reflect the most recent SEC 13F filing dated May 15, 2026, providing an updated snapshot of assets under management.

The portfolio balances highlight BIOGEN INC (BIIB) as the single largest position, accounting for 3.8% of total equity value, followed by DUPONT DE NEMOURS INC (DD), WARNER BROS DISCOVERY INC (WBD), GSK PLC (GSK), and others. Collectively, the top five holdings represent 18.7% of the portfolio, showing how capital is distributed among core positions and long-term investments.